UPDATE New Family of Fanless Industrial Computers with Industry-Leading I/O & Performance
April 17, 2024 15:50 ET
|
Sealevel Systems, Inc.
LIBERTY, SC USA, April 17, 2024 (GLOBE NEWSWIRE) -- Sealevel Systems announces a new family of computers, the Flexio Fanless Industrial Embedded Computers. Fueled by a Quad-core Intel Atom or Core...
SHAREHOLDER ALERT: Malibu Boats Investigated by Block & Leviton For Potential Securities Law Violations: Investors Who Have Lost Money Are Encouraged to Contact the Firm
April 17, 2024 15:47 ET
|
Block & Leviton LLP
BOSTON, April 17, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Malibu Boats, Inc. (NASDAQ: MBUU) for potential securities law violations. Investors who have lost money in their...
Fortiva® Retail Credit Announces Second Look Financing Program with Byte
April 17, 2024 15:30 ET
|
Atlanticus Holdings Corp
ATLANTA, April 17, 2024 (GLOBE NEWSWIRE) -- Atlanticus Holdings Corporation (NASDAQ: ATLC) (“Atlanticus”, “we” or “our”) today announced that a multi-year program with Byte, a leading at-home clear...
Union Bankshares Announces Earnings for the three months ended March 31, 2024 and Declares Quarterly Dividend
April 17, 2024 15:30 ET
|
Union Bankshares, Inc.
MORRISVILLE, Vt., April 17, 2024 (GLOBE NEWSWIRE) -- Union Bankshares, Inc. (NASDAQ - UNB) today announced results for the three months ended March 31, 2024 and declared a regular quarterly cash...
Global Pediatric Drugs And Vaccines Market Size To Exceed USD 265.5 Billion By 2033 | CAGR of 8.04%
April 17, 2024 15:30 ET
|
SPHERICAL INSIGHTS LLP
New York, United States, April 17, 2024 (GLOBE NEWSWIRE) -- The Global Pediatric Drugs and Vaccines Market Size is to Grow from USD 122.5 Billion in 2023 to USD 265.5 Billion by 2033, at a Compound...
ClearPoint Neuro feliciteert partner AviadoBio met de behandeling van de eerste patiënt in klinisch onderzoek ASPIRE-FTD, waarin AVB-101 wordt geëvalueerd voor frontotemporale dementie met GRN-mutaties
April 17, 2024 15:21 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Californië, April 17, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (het “bedrijf”), een internationaal bedrijf dat zich toelegt op hulpmiddelen, cel- en...
ClearPoint Neuro felicita a su socio AviadoBio por el primer paciente tratado en su ensayo clínico ASPIRE-FTD que evalúa AVB-101 en personas con demencia frontotemporal con mutaciones en el gen GRN
April 17, 2024 15:21 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, California, April 17, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (la «empresa»), una compañía global de dispositivos, células y terapia génica que ofrece navegación...
ClearPoint Neuro si congratula con il proprio partner AviadoBio per il primo paziente trattato nello studio clinico ASPIRE-FTD, che valuta la terapia genica sperimentale AVB-101 per la demenza frontotemporale con mutazioni GRN
April 17, 2024 15:21 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, California, April 17, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (la “Società”), un’azienda globale di dispositivi, cellule e terapie geniche che offre una...
ClearPoint Neuro beglückwünscht seinem Partner AviadoBio zur Behandlung des ersten Patienten in der klinischen Studie ASPIRE-FTD, in der AVB-101 für frontotemporale Demenz mit GRN-Mutationen evaluiert wird
April 17, 2024 15:21 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Kalifornien, April 17, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (das „Unternehmen“), ein globales Unternehmen für Geräte, Zellen und Gentherapie, das präzise...
ClearPoint Neuro félicite son partenaire AviadoBio pour son premier patient traité dans le cadre de son essai clinique ASPIRE-FTD évaluant l’AVB-101 dans la démence fronto-temporale avec mutations du gène GRN
April 17, 2024 15:21 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Californie, 17 avr. 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq : CLPT) (la « Société »), une société mondiale spécialisée dans les dispositifs, de thérapie cellulaire et...